{"id":"https://openalex.org/W7204652410","doi":"https://doi.org/10.1016/j.rpth.2026.106936","title":"Perspectives: what we are learning from factor XI/factor XIa inhibitor trials","display_name":"Perspectives: what we are learning from factor XI/factor XIa inhibitor trials","publication_year":2026,"publication_date":"2026-08-29","ids":{"openalex":"https://openalex.org/W7204652410","doi":"https://doi.org/10.1016/j.rpth.2026.106936","pmid":"https://pubmed.ncbi.nlm.nih.gov/42936046","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13700345"},"language":"en","primary_location":{"id":"doi:10.1016/j.rpth.2026.106936","doi":"https://doi.org/10.1016/j.rpth.2026.106936","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rpth.2026.106936","pdf_url":"https://www.rpthjournal.org/article/S2475-0379(26)03594-6/pdf","source":{"id":"https://openalex.org/S4210185368","display_name":"Research and Practice in Thrombosis and Haemostasis","issn_l":"2475-0379","issn":["2475-0379"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and Practice in Thrombosis and Haemostasis","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.rpthjournal.org/article/S2475-0379(26)03594-6/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5120103897","display_name":"Melissa F. Glasner","orcid":"https://orcid.org/0009-0001-7706-1288","observed_orcids":["https://orcid.org/0009-0001-7706-1288"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Melissa F. Glasner","raw_affiliation_strings":["Department of Medical Education, The France Foundation, Old Lyme, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Education, The France Foundation, Old Lyme, Connecticut, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082464840","display_name":"Jeffrey Ian Weitz","orcid":"https://orcid.org/0000-0002-1092-7550","observed_orcids":["https://orcid.org/0000-0002-1092-7550"]},"institutions":[{"id":"https://openalex.org/I4210155985","display_name":"Thrombosis and Atherosclerosis Research Institute","ror":"https://ror.org/04j9w6p53","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4210155985"]},{"id":"https://openalex.org/I98251732","display_name":"McMaster University","ror":"https://ror.org/02fa3aq29","country_code":"CA","type":"education","lineage":["https://openalex.org/I98251732"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jeffrey I. Weitz","raw_affiliation_strings":["Department of Medicine and Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada","institution_ids":["https://openalex.org/I4210155985","https://openalex.org/I98251732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136183454","display_name":"Rasha Al-Lamee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I153355300","display_name":"Imperial College Healthcare NHS Trust","ror":"https://ror.org/056ffv270","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rasha Al-Lamee","raw_affiliation_strings":["National Heart and Lung Institute, Imperial College Healthcare NHS, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Heart and Lung Institute, Imperial College Healthcare NHS, London, UK","institution_ids":["https://openalex.org/I153355300","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136148220","display_name":"Mar\u00eda Cecilia Bahit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120277","display_name":"Instituto de Neurolog\u00eda Cognitiva","ror":"https://ror.org/02vt2xa24","country_code":"AR","type":"facility","lineage":["https://openalex.org/I4210120277"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Mar\u00eda Cecilia Bahit","raw_affiliation_strings":["Department INECO Neurociencias, World Stroke Organization Heart and Brain Task Force, Rosario, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department INECO Neurociencias, World Stroke Organization Heart and Brain Task Force, Rosario, Argentina","institution_ids":["https://openalex.org/I4210120277"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005706983","display_name":"Jonathan M. Coutinho","orcid":"https://orcid.org/0000-0002-8284-982X","observed_orcids":["https://orcid.org/0000-0002-8284-982X","https://orcid.org/0000-0001-9941-4155"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jonathan M. Coutinho","raw_affiliation_strings":["Department of Neurology, Amsterdam University Medical Center, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Amsterdam University Medical Center, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I4210151833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001594817","display_name":"S. Claiborne Johnston","orcid":"https://orcid.org/0000-0002-2912-0714","observed_orcids":["https://orcid.org/0000-0002-2912-0714"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Claiborne Johnston","raw_affiliation_strings":["Department of Neurology, University of California, San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of California, San Francisco, California, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021496734","display_name":"David Gailani","orcid":"https://orcid.org/0000-0001-8142-8014","observed_orcids":["https://orcid.org/0000-0001-8142-8014"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Gailani","raw_affiliation_strings":["Division of Hematology Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067422552","display_name":"Carolyn S.P. Lam","orcid":"https://orcid.org/0000-0003-1903-0018","observed_orcids":["https://orcid.org/0000-0003-1903-0018"]},"institutions":[{"id":"https://openalex.org/I4210107866","display_name":"National University Heart Centre Singapore","ror":"https://ror.org/01vvdem88","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I4210107866"]},{"id":"https://openalex.org/I4210147238","display_name":"National Heart Centre Singapore","ror":"https://ror.org/04f8k9513","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I4210147238"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Carolyn S.P. Lam","raw_affiliation_strings":["Department of Cardiology and Director of Women's Heart Health, National Heart Centre Singapore, Duke-National University, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology and Director of Women's Heart Health, National Heart Centre Singapore, Duke-National University, Singapore, Singapore","institution_ids":["https://openalex.org/I4210107866","https://openalex.org/I4210147238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033748408","display_name":"Tzu\u2010Fei Wang","orcid":"https://orcid.org/0000-0003-2407-9000","observed_orcids":["https://orcid.org/0000-0003-2407-9000"]},"institutions":[{"id":"https://openalex.org/I153718931","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16","country_code":"CA","type":"education","lineage":["https://openalex.org/I153718931"]},{"id":"https://openalex.org/I2800722420","display_name":"Ottawa Hospital","ror":"https://ror.org/03c62dg59","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800722420"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Tzu-Fei Wang","raw_affiliation_strings":["Division of Hematology, University of Ottawa, the Ottawa Hospital, Ottawa, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, University of Ottawa, the Ottawa Hospital, Ottawa, Ontario, Canada","institution_ids":["https://openalex.org/I153718931","https://openalex.org/I2800722420"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014965271","display_name":"Wolfgang C. Winkelmayer\u00ad","orcid":"https://orcid.org/0000-0002-5272-425X","observed_orcids":["https://orcid.org/0000-0002-5272-425X"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wolfgang C. Winkelmayer","raw_affiliation_strings":["Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, Texas, USA","institution_ids":["https://openalex.org/I181547552"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5120103897"],"corresponding_institution_ids":[],"apc_list":{"value":2250,"currency":"USD","value_usd":2250},"apc_paid":{"value":2250,"currency":"USD","value_usd":2250},"fwci":1.2512,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.82244745,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"10","issue":"Suppl 3","first_page":"106936","last_page":"106936"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.625,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.625,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.2741999924182892,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.05139999836683273,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-xi-inhibition","display_name":"factor XI inhibition","score":0.7929999828338623},{"id":"https://openalex.org/keywords/factor-xia-inhibitors","display_name":"factor XIa inhibitors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/intrinsic-coagulation-pathway","display_name":"intrinsic coagulation pathway","score":0.7879999876022339},{"id":"https://openalex.org/keywords/antithrombotic-therapy","display_name":"antithrombotic therapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/thromboprophylaxis","display_name":"thromboprophylaxis","score":0.9800000190734863},{"id":"https://openalex.org/keywords/secondary-stroke-prevention","display_name":"secondary stroke prevention","score":0.8849999904632568},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.8939999938011169},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cancer-associated-thrombosis","display_name":"cancer-associated thrombosis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/major-bleeding","display_name":"major bleeding","score":0.7179999947547913},{"id":"https://openalex.org/keywords/thrombin-generation","display_name":"thrombin generation","score":0.6330000162124634},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.8080000281333923},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9549999833106995},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9779999852180481},{"id":"https://openalex.org/keywords/sirna","display_name":"siRNA","score":0.8479999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5332000255584717},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3264000117778778},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2971999943256378},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2793999910354614},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26179999113082886},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.24660000205039978},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2418999969959259},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2393999993801117},{"id":"https://openalex.org/C168167062","wikidata":"https://www.wikidata.org/wiki/Q1117970","display_name":"Component (thermodynamics)","level":2,"score":0.22269999980926514},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.22130000591278076}],"mesh":[{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005172","descriptor_name":"Factor XI","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D005172","descriptor_name":"Factor XI","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015945","descriptor_name":"Factor XIa","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015945","descriptor_name":"Factor XIa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.rpth.2026.106936","doi":"https://doi.org/10.1016/j.rpth.2026.106936","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rpth.2026.106936","pdf_url":"https://www.rpthjournal.org/article/S2475-0379(26)03594-6/pdf","source":{"id":"https://openalex.org/S4210185368","display_name":"Research and Practice in Thrombosis and Haemostasis","issn_l":"2475-0379","issn":["2475-0379"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and Practice in Thrombosis and Haemostasis","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13700345","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13700345/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13700345/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Res Pract Thromb Haemost","raw_type":"Text"},{"id":"pmid:42936046","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42936046","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and practice in thrombosis and haemostasis","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:bab58e931311437d942e6e1bfcf27ca8","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/bab58e931311437d942e6e1bfcf27ca8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research and Practice in Thrombosis and Haemostasis, Vol 10, Iss , Pp 106936- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.rpth.2026.106936","doi":"https://doi.org/10.1016/j.rpth.2026.106936","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rpth.2026.106936","pdf_url":"https://www.rpthjournal.org/article/S2475-0379(26)03594-6/pdf","source":{"id":"https://openalex.org/S4210185368","display_name":"Research and Practice in Thrombosis and Haemostasis","issn_l":"2475-0379","issn":["2475-0379"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and Practice in Thrombosis and Haemostasis","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309974","display_name":"Bayer Corporation","ror":"https://ror.org/034ffbg36"},{"id":"https://openalex.org/F4320315802","display_name":"International Society on Thrombosis and Haemostasis","ror":"https://ror.org/03c33yc55"},{"id":"https://openalex.org/F4320319519","display_name":"Anthos Therapeutics","ror":"https://ror.org/03x28jt92"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204652410.pdf","grobid_xml":"https://content.openalex.org/works/W7204652410.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W1913544684","https://openalex.org/W1971585818","https://openalex.org/W1979338133","https://openalex.org/W1984934540","https://openalex.org/W1998399069","https://openalex.org/W2002431523","https://openalex.org/W2004721076","https://openalex.org/W2031677121","https://openalex.org/W2059991147","https://openalex.org/W2102719739","https://openalex.org/W2104405457","https://openalex.org/W2338854794","https://openalex.org/W2350361926","https://openalex.org/W2561678715","https://openalex.org/W2566868848","https://openalex.org/W2999873990","https://openalex.org/W3042948068","https://openalex.org/W3164820582","https://openalex.org/W3164883358","https://openalex.org/W3201467365","https://openalex.org/W3209083413","https://openalex.org/W3212517452","https://openalex.org/W3217418295","https://openalex.org/W4223439574","https://openalex.org/W4293410865","https://openalex.org/W4293678347","https://openalex.org/W4296902187","https://openalex.org/W4386220241","https://openalex.org/W4387816364","https://openalex.org/W4388731368","https://openalex.org/W4389657620","https://openalex.org/W4390706736","https://openalex.org/W4391883120","https://openalex.org/W4393411546","https://openalex.org/W4402022435","https://openalex.org/W4402111423","https://openalex.org/W4402724129","https://openalex.org/W4405047501","https://openalex.org/W4406722802","https://openalex.org/W4407735095","https://openalex.org/W4407762805","https://openalex.org/W4411149739","https://openalex.org/W4411534911","https://openalex.org/W4416040817","https://openalex.org/W7124910436","https://openalex.org/W7133487597","https://openalex.org/W7154457604","https://openalex.org/W7161157219"],"related_works":["https://openalex.org/W7214939951","https://openalex.org/W4390031677","https://openalex.org/W4391527531","https://openalex.org/W2013971726","https://openalex.org/W7135380835","https://openalex.org/W7172448618","https://openalex.org/W2139652623","https://openalex.org/W4315644954","https://openalex.org/W4409791655","https://openalex.org/W7220446070"],"abstract_inverted_index":{"Over":[0],"the":[1],"past":[2],"decade,":[3],"a":[4,39,128],"diverse":[5,154],"pipeline":[6],"of":[7,47,108],"factor":[8],"XI":[9],"(FXI)/XIa-targeting":[10],"agents":[11,35],"has":[12,83],"entered":[13],"clinical":[14,32,67,148],"development,":[15],"including":[16],"oral":[17],"small-molecule":[18],"inhibitors,":[19],"monoclonal":[20],"antibodies,":[21],"antisense":[22],"oligonucleotides,":[23],"and":[24,30,76,97,150],"small":[25],"interfering":[26],"RNAs.":[27],"Across":[28],"early-":[29],"late-phase":[31],"trials,":[33],"these":[34,122],"have":[36,64,100],"generally":[37],"shown":[38,84],"favorable":[40],"safety":[41],"profile,":[42],"with":[43,53,58,114,138],"consistently":[44],"low":[45],"rates":[46],"major":[48],"bleeding,":[49],"even":[50],"when":[51],"used":[52],"antiplatelet":[54],"therapy":[55,134],"or":[56,118],"compared":[57],"standard":[59],"anticoagulants.":[60],"However,":[61],"efficacy":[62,103],"signals":[63],"varied":[65],"by":[66],"setting.":[68],"In":[69,88],"venous":[70],"thromboembolism":[71],"prophylaxis":[72],"after":[73],"orthopedic":[74],"surgery":[75],"in":[77,91,112,132],"secondary":[78],"stroke":[79],"prevention,":[80],"FXI/XIa":[81,125],"inhibition":[82,111],"encouraging":[85],"antithrombotic":[86,133],"activity.":[87],"contrast,":[89],"trials":[90],"atrial":[92],"fibrillation,":[93],"acute":[94],"coronary":[95],"syndrome,":[96],"cancer-associated":[98],"thrombosis":[99],"yielded":[101],"mixed":[102],"results,":[104],"highlighting":[105],"potential":[106,129],"limitations":[107],"intrinsic":[109],"pathway":[110],"conditions":[113],"high":[115],"thrombin":[116],"generation":[117],"platelet-driven":[119],"thrombosis.":[120],"Collectively,":[121],"findings":[123],"position":[124],"inhibitors":[126],"as":[127],"paradigm":[130],"shift":[131],"for":[135],"targeted":[136],"indications,":[137],"ongoing":[139],"phase":[140],"3":[141],"studies":[142],"expected":[143],"to":[144],"further":[145],"define":[146],"their":[147],"role":[149],"optimal":[151],"use":[152],"across":[153],"thrombotic":[155],"disorders.":[156]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-08-30T00:00:00"}